Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 15/20 | 0.66 |
| ▸ | CA1 | P00915 | 13/20 | 0.66 |
| ▸ | CA9 | Q16790 | 5/20 | 0.53 |
| ▸ | CA12 | O43570 | 9/20 | 0.46 |
| ▸ | CA7 | P43166 | 9/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 9/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14095683 | 0.88 | CA2 (0.53) | CA2CA1CA9CA12CA7 | |
| SCHEMBL776677 | 0.76 | CA2 (0.61) | CA2CA1CA9CA12CA7 | |
| SCHEMBL3688171 | 0.75 | CA2 (0.50) | CA2CA1CA9CA12CA7 | |
| SCHEMBL9658427 | 0.75 | CA2 (0.59) | CA2CA1CA9CA12CA7 | |
| SCHEMBL7286478 | 0.75 | CA2 (0.59) | CA2CA1CA9CA12CA7 | |
| SCHEMBL1263515 | 0.74 | CA2 (0.63) | CA2CA1CA9CA12CA7 | |
| SCHEMBL28624040 | 0.73 | CA2 (0.68) | CA2CA1CA9CA12CA7 | |
| SCHEMBL561014 | 0.73 | CA2 (0.68) | CA2CA1CA9CA12CA7 | |
| SCHEMBL776873 | 0.73 | CA2 (0.47) | CA2CA1CA9CA12CA7 | |
| SCHEMBL6888520 | 0.73 | TDP1 (0.41) | CA2CA1CA12CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100150835-A1 | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate | GE HEALTHCARE LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20100150835-A1 | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate | GE HEALTHCARE LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20100150835-A1 | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate | GE HEALTHCARE LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20100150835-A1 | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate | GE HEALTHCARE LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| WO-2008106442-A1 | SYNTHESIS OF [18F] FLUOROMETHYL BENZENE USING BENZYL PENTAFLUOROBENZENESULFONATE | GE HEALTHCARE LIMITED (GB) | 2008-09-04 | — | — | WO | disclosed |
| WO-2008106442-A1 | SYNTHESIS OF [18F] FLUOROMETHYL BENZENE USING BENZYL PENTAFLUOROBENZENESULFONATE | GE HEALTHCARE LIMITED (GB) | 2008-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100150835-A1 | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate | PFAS, FES, CDC73 | CA2 3960/4885CA1 3537/4885CA9 2124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.